| Shammas, Nicolas W |
| Completed | N/A | 133 | US | AngioSafe Peripheral CTO Crossing System | AngioSafe, Inc., Veranex, Inc. | Peripheral Artery Occlusion, Peripheral Arterial Disease | 04/23 | 06/23 | | |
| Recruiting | N/A | 292 | Europe, US | MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal Angioplasty (PTA) Device | REVA Medical, Inc. | Critical Limb Ischemia | 09/25 | 03/29 | | |
| Recruiting | N/A | 30 | US | Doraya catheter | Revamp Medical Inc. | Acute Decompensated Heart Failure | 12/24 | 03/25 | | |
ECLIPSE, NCT03108456: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The Trial |
|
|
| Active, not recruiting | N/A | 2005 | US | Orbital Atherectomy, Balloon | Abbott Medical Devices, Cardiovascular Research Foundation, New York | Coronary Artery Disease, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction | 06/24 | 06/25 | | |
DEEPER REVEAL, NCT05358353: A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee |
|
|
| Recruiting | N/A | 130 | US | Bare Temporary Spur Stent System | ReFlow Medical, Inc. | Peripheral Arterial Disease, Critical Limb Ischemia | 10/24 | 10/24 | | |
| Recruiting | N/A | 288 | US | PCB, AcoArt Litos PCB, PTA | Acotec Scientific Co., Ltd | Chronic Limb-Threatening Ischemia | 11/31 | 02/32 | | |
| Spector, David M |
CompassHER2 RD, NCT04457596: T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the Trial |
|
|
| Recruiting | 3 | 1031 | Canada, US | Trastuzumab Emtansine, Placebo Administration, Tucatinib, Questionnaire Administration, Quality-of-Life Assessment | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), Seagen Inc. | Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Invasive Breast Carcinoma, Multifocal Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Synchronous Bilateral Breast Carcinoma | 01/28 | 05/35 | | |
|
| Mehran, Roxana |
NCT01456013: Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients |
|
|
| Active, not recruiting | 3 | 326 | US | RenalGuard Therapy, Standard Therapy | CardioRenal Systems, Inc. | Contrast Induced Nephropathy | 03/18 | 12/24 | | |
| Completed | N/A | 19000 | US | Percutaneous coronary intervention | Abbott Medical Devices, Icahn School of Medicine at Mount Sinai | Coronary Artery Disease, Percutaneous Coronary Intervention | 02/21 | 10/23 | | |
ABILITY, NCT04236609: Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global |
|
|
| Active, not recruiting | N/A | 3050 | Europe, RoW | Abluminus DES+ Sirolimus Eluting Stent System (SES), XIENCE Everolimus Eluting Coronary Stent System (XIENCE family) | Concept Medical Inc. | Diabetes, Coronary Artery Disease, Acute Coronary Syndrome | 10/23 | 09/24 | | |
| Active, not recruiting | N/A | 418 | Europe, Canada, US, RoW | SELUTION SLR™ DEB, Control | M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation | Coronary Restenosis | 07/25 | 08/29 | | |
| Active, not recruiting | N/A | 716 | Europe, Canada, US, RoW | Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV Systems, Edwards SAPIEN 3 or SAPIEN 3 Ultra THV Systems | Medtronic Cardiovascular | Symptomatic Aortic Stenosis, Aortic Valve Stenosis, Aortic Valve Replacement | 11/23 | 12/27 | | |
| Completed | N/A | 322 | US | Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) | Element Science, Inc. | Sudden Cardiac Arrest | 11/23 | 11/23 | | |
| Recruiting | N/A | 500 | NA | ProtEmbo - Cerebral Embolic Protection, Sentinel - Cerebral Embolic Protection | Protembis GmbH | Severe Aortic Valve Stenosis | 06/25 | 07/25 | | |
| SHAMMAS, GAIL |
NCT05618691: A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC) |
|
|
| Withdrawn | 2 | 100 | US | GFH312, Placebo | Zhejiang Genfleet Therapeutics Co., Ltd. | Intermittent Claudication, Peripheral Artery Disease | 12/23 | 05/24 | | |
| Recruiting | N/A | 292 | Europe, US | MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal Angioplasty (PTA) Device | REVA Medical, Inc. | Critical Limb Ischemia | 09/25 | 03/29 | | |
ECLIPSE, NCT03108456: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The Trial |
|
|
| Active, not recruiting | N/A | 2005 | US | Orbital Atherectomy, Balloon | Abbott Medical Devices, Cardiovascular Research Foundation, New York | Coronary Artery Disease, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction | 06/24 | 06/25 | | |
DEEPER REVEAL, NCT05358353: A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee |
|
|
| Recruiting | N/A | 130 | US | Bare Temporary Spur Stent System | ReFlow Medical, Inc. | Peripheral Arterial Disease, Critical Limb Ischemia | 10/24 | 10/24 | | |
| Recruiting | N/A | 288 | US | PCB, AcoArt Litos PCB, PTA | Acotec Scientific Co., Ltd | Chronic Limb-Threatening Ischemia | 11/31 | 02/32 | | |
| Weakley, Desyree |
| No trials found |
| Robken, Jon |
| No trials found |
